A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies. [electronic resource]
Producer: 20070327Description: 727-31 p. digitalISSN:- 0090-8258
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Cetuximab
- Drug Resistance, Neoplasm
- ErbB Receptors -- biosynthesis
- Female
- Humans
- Middle Aged
- Organoplatinum Compounds -- pharmacology
- Ovarian Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.